Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant lysostaphin topical solution in deep second-degree burn wounds with MRSA infection
CTR20160822Phase 3Terminated
- Sponsor
- Shanghai Gaoke United Biotechnology Research and Development
- Start
- Nov 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of staphylolysin in burn wound infection, burn injury, sponsored by Shanghai Gaoke United Biotechnology Research and Development. Started Nov 2016; status: terminated.
02
Drugs
staphylolysin
03
Conditions
burn wound infectionburn injury
Beyond the preview
Go deeper on CTR20160822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160822.